Mazumdar Claire — SEC Form 4 filings

SEC reporting owner CIK 2034671. 14 Form 4 filings on record with FilingPulse; latest filed 2026-08-12.

Transaction summary — filings shown

Covers all 14 filings on record, filed 2025-06-11 to 2026-08-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Bicara Therapeutics Inc. (BCAX)Chief Executive Officer, Director1217 legs · 200,000 sh · $4,057,14639
Relay Therapeutics, Inc. (RLAY)Director22

Form 4 filings — Mazumdar Claire

FiledFormIssuerReported transactionsSource
2026-08-124Bicara Therapeutics Inc. (BCAX)Option exercise (M): 10,000 @ $3.79 · Sale (S): 10,000 @ $27.98 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2026-07-144Bicara Therapeutics Inc. (BCAX)Option exercise (M): 10,000 @ $3.79 · Sale (S): 9,972 @ $28.42 · Sale (S): 28 @ $29.68 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2026-06-104Relay Therapeutics, Inc. (RLAY)Grant/award (A): 32,947 (derivative) @ $0EDGAR
2026-05-204Bicara Therapeutics Inc. (BCAX)Option exercise (M): 15,000 @ $3.79 · Sale (S): 12,022 @ $19.96 · Sale (S): 2,978 @ $20.35 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2026-04-204Bicara Therapeutics Inc. (BCAX)Option exercise (M): 8,226 @ $4.44 · Option exercise (M): 7,454 @ $3.79 · Option exercise (M): 7,080 @ $5.45 · Option exercise (M): 15,000 @ $3.79 · Sale (S): 15,000 @ $23.61 · Option exercise (M): 8,226 (derivative) @ $0 · +3 moreEDGAR
2026-03-204Bicara Therapeutics Inc. (BCAX)Option exercise (M): 6,499 @ $3.79 · Sale (S): 6,499 @ $18.84 · Option exercise (M): 6,905 @ $3.79 · Sale (S): 6,905 @ $18.78 · Option exercise (M): 1,596 @ $3.79 · Sale (S): 1,596 @ $18.95 · +3 moreEDGAR
2026-03-114Bicara Therapeutics Inc. (BCAX)Option exercise (M): 36,766 @ $3.79 · Sale (S): 36,766 @ $19.17 · Option exercise (M): 36,766 (derivative) @ $0EDGAR
2026-03-064Bicara Therapeutics Inc. (BCAX)Option exercise (M): 2,631 @ $3.79 · Sale (S): 2,631 @ $18.73 · Option exercise (M): 1,786 @ $3.79 · Sale (S): 1,786 @ $18.74 · Option exercise (M): 3,817 @ $3.79 · Sale (S): 3,817 @ $18.75 · +3 moreEDGAR
2026-02-044Bicara Therapeutics Inc. (BCAX)Grant/award (A): 450,000 (derivative) @ $0EDGAR
2025-12-184Bicara Therapeutics Inc. (BCAX)Option exercise (M): 29,500 @ $5.45 · Option exercise (M): 29,500 (derivative) @ $0EDGAR
2025-11-254Bicara Therapeutics Inc. (BCAX)Option exercise (M): 41,163 @ $3.79 · Sale (S): 41,163 @ $18.86 · Option exercise (M): 41,163 (derivative) @ $0EDGAR
2025-10-204Bicara Therapeutics Inc. (BCAX)Option exercise (M): 24,103 @ $3.79 · Sale (S): 24,103 @ $18.83 · Option exercise (M): 24,103 (derivative) @ $0EDGAR
2025-10-154Bicara Therapeutics Inc. (BCAX)Option exercise (M): 11,445 @ $3.79 · Sale (S): 11,445 @ $18.92 · Option exercise (M): 13,289 @ $3.79 · Sale (S): 13,289 @ $18.84 · Option exercise (M): 11,445 (derivative) @ $0 · Option exercise (M): 13,289 (derivative) @ $0EDGAR
2025-06-114Relay Therapeutics, Inc. (RLAY)Grant/award (A): 421,241 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2034671 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →